WASHINGTON - The Food and Drug Administration has approved changes to the labeling of six hormone therapy products used to ...

The FDA approved changes to the labels for six menopausal hormone therapy products in a move the agency said clarifies risk ...

The FDA has approved drug label changes to six menopausal hormone replacement therapies (HRT), according to a recent news release. This was done to clarify risks for taking these drugs, specifically ...

The FDA has lifted longstanding and the most severe warnings off of hormone replacement therapies for menopausal women.

Boxed warnings on cardiovascular disease, breast cancer, and probable dementia are no more ...

WEST MICHIGAN — Menopause is the term to describe women no longer receiving natural estrogen from her ovaries, and for several years, women who would be excellent candidates for Menopause Hormone ...

Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the Food and Drug ...

Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia, and other serious risks, the Food and Drug ...

More changes are coming from the Food and Drug Administration as officials move to get rid of warning labels on some medications.Just last month, the administration announced it will remove black box ...

Complete DPD deficiency markedly impairs 5-FU catabolism, increasing risk of early severe diarrhea, mucositis, neutropenia, ...